A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Public ClinicalTrials.gov record NCT02734693. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the efficacy and safety of dasotraline in children 6 years of age to 12 years of age with Attention-Deficit Hyperactivity Disorder (ADHD) in a simulated classroom setting.
Study identification
- NCT ID
- NCT02734693
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 132 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2016
- Primary completion
- Feb 27, 2017
- Completion
- Feb 27, 2017
- Last update posted
- Mar 26, 2020
2016 – 2017
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Avida Inc | Newport Beach | California | 92660 | — |
| Meridien Research | Bradenton | Florida | 34201 | — |
| Florida Clinical Research Center, LLC | Maitland | Florida | 32751 | — |
| Center for Psychiatry and Behavioral Medicine, Inc. | Las Vegas | Nevada | 89128 | — |
| Bayou City Research, Ltd | Houston | Texas | 77007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Attention-Deficit Hyperactivity Disorder (ADHD) trials
Other public records listing Attention-Deficit Hyperactivity Disorder (ADHD). Sorted by last update posted; newest first. Not a recommendation.
- NCT07793045: Binaural Beats Stimulation for Adults With ADHD Recruiting
- NCT07654205: Smartphone-based Intervention for Young Adults With ADHD Recruiting
- NCT07226219: Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease Recruiting
- NCT06810180: Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD Recruiting
- NCT06853665: The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine Recruiting
- NCT06960980: Improving ADHD Teen Driving - Virtual Reality Recruiting
All Attention-Deficit Hyperactivity Disorder (ADHD) trials →
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02734693, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2020 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02734693 live on ClinicalTrials.gov.